EXHIBIT 11
CYTOCLONAL PHARMACEUTICS INC.
COMPUTATION OF NET (LOSS) PER COMMON SHARE
(unaudited)
THREE MONTHS NINE MONTHS
ENDED SEPTEMBER 30, ENDED SEPTEMBER 30,
1996 1997 1996 1997
----------- ------------ ------------ ------------
Net (loss) $ (808,000) $ (945,000) $(2,128,000) $(2,462,000)
Add cumulative preferred dividend (79,000) (69,000) (238,000) (207,000)
---------- ----------- ----------- -----------
NET (LOSS) USED FOR COMPUTATION $ (887,000) $(1,014,000) $(2,366,000) $(2,669,000)
---------- ----------- ----------- -----------
---------- ----------- ----------- -----------
Weighted average number of
common shares outstanding 7,687,000 8,261,000 7,631,000 8,136,000
---------- ----------- ----------- -----------
---------- ----------- ----------- -----------
Net (loss) per common share $(0.12) $(0.12) $(0.31) $(0.33)
---------- ----------- ----------- -----------
---------- ----------- ----------- -----------
11